ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CELL PhenomeX Inc

0.9981
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
PhenomeX Inc CELL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.9981 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9981 0.9981
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/2/202416:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/10/202308:00EDGAR2Form 15-12G - Securities registration termination [Section..
03/10/202314:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202314:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202313:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202316:16EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
02/10/202316:06EDGAR2Form S-8 POS - Securities to be offered to employees in..
02/10/202307:47EDGAR2Form 8-K - Current report
29/9/202307:30EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/9/202307:51PRNUSPhenomeX Announces Opto® Memory B Discovery Human Workflow..
21/9/202307:35PRNUSPhenomeX Announces the Release of SpotLight™ Human Lambda..
20/9/202307:48PRNUSPhenomeX to Participate in Upcoming Cell Biology Conferences
20/9/202305:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/9/202308:08PRNUSPhenomeX Unveils Meteor™ Chips For Quantitative Bulk..
05/9/202315:02PRNUSPhenomeX Inc. Announces Commencement of Cash Tender Offer by..
31/8/202315:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/8/202316:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/8/202316:21EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202316:28EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202316:27EDGAR2Form 8-K - Current report
17/8/202308:10EDGAR2Form SC14D9C - Written communication relating to third party..
17/8/202308:09EDGAR2Form 8-K - Current report
17/8/202308:00BWBruker Corporation and PhenomeX Inc. Announce Definitive..
14/8/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:09EDGAR2Form 8-K - Current report
14/8/202315:05PRNUSPhenomeX Reports Second Quarter 2023 Financial Results and..
09/8/202315:25PRNUSPhenomeX to Report Second Quarter 2023 Financial Results on..
07/8/202307:11PRNUSPhenomeX Announces Lifting of the Stay in AbCellera Patent..
28/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202317:15EDGAR2Form 144 - Report of proposed sale of securities
07/7/202315:15EDGAR2Form 8-K - Current report
13/6/202308:32PRNUSPhenomeX's Beacon® Technology Enables Early Identification..
05/6/202307:46PRNUSPhenomeX Launches Beacon Quest™ Optofluidic System with..
15/5/202308:01PRNUSPhenomeX Launches Beacon Select™ Optofluidic System with..
11/5/202315:02PRNUSPhenomeX Reports First Quarter 2023 Financial Results
11/5/202308:35PRNUSPhenomeX To Participate in 19th Annual PEGS Boston..

Su Consulta Reciente

Delayed Upgrade Clock